Boehringer facing more than 2,000 U.S. lawsuits over blood thinner

German drugmaker Boehringer Ingelheim said on Thursday it is facing more than 2,000 lawsuits in the United States over claims its blockbuster drug Pradaxa, the first in a new class of stroke prevention pills, caused severe and fatal bleeding.

Reuters, Feb 13, 2014